Ardelyx Inc (ARDX)
followers
·
Follow
| Sector: | HEALTH CARE |
| Industry: | BIOTECHNOLOGY & LIFE SCIENCES |
| SIC: | PHARMACEUTICAL PREPARATIONS |
| CEO: | Michael G. Raab |
| Employees: | 90 |
| Web site: | ardelyx.com |
|
34175 ARDENWOOD BLVD., FREMONT, CA, 94555
510-745-7047
| |
| All 13F Filers | Prior | Change | Hedge Funds 1 | Prior | Change |
|---|
Ardelyx, Inc. discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel syndrome with constipation. It is also developing RDX013, a potassium secretagogue, for the. treatment of elevated serum potassium, or hyperkalemia, among certain patients with kidney and/or heart disease.
Please log in first to see chart